A specific N-linked glycosylation inhibitor- tunicamycin can result in a reduction in the molecular weight of PD-L2 by approximately 15 kDa in two colorectal cancer (CRC) cell lines [71]. The gene discussed is PDCD1LG2; the disease is colorectal carcinoma.